FDA weighs drug repurposing pathway for underserved diseases - Pharmaceutical Technology

Approved drugs could be expanded into disease areas with limited commercial potential, providing supporting data is available. Approved drugs could be expanded into disease areas with limited commercial potential, providing supporting data is available. A main goal of the repurposing drive is to expand treatment options in disease areas with significant unmet need. Credit: Jolanta Mosakovska/Shutterstock.com. The US Food and Drug Administration (FDA) is considering a new framework that could allow approved medicines to be repurposed for additional indications, particularly in disease areas with limited commercial incentives. The FDA is seeking industry and public opinion on the initiative , which…

Source: Pharmaceutical Technology